A Novel Report About Global Tobacco Consumption Issued by WHO

 

Tablo reader up chevron

According to the latest World Health Organization (WHO) projections, there is a decline in the number of men using tobacco, indicating a huge change in the global tobacco epidemic.  

 

“In the past two decades, the total number of global tobacco users has fallen down from 1.397 billion in 2000 to 1.337 billion in 2018, a decrease of about 60 million,”—the 3rd edition of the WHO Report on Global Tobacco Use Trends 2000-2025. The decrease of tobacco use indicates that the government control could protect some certain group of people, especially males from being harmed by the overuse of tobacco, and therefore save their life.  

 

Annually, there are an estimated 8 million who people died of tobacco, occupying half of the overall group who use it, among whom 1.2 million are nonsmokers but killed by passive smoking. Major damage of passive smoking lies in:

 

  • For adults, secondhand smoke can cause serious cardiovascular and respiratory diseases, including coronary heart disease and lung cancer.
  • For infants, secondhand smoke increases the risk of sudden infant death.
  • For pregnant women, secondhand smoke can lead to pregnancy complications and low birth weight.

 

It can be inferred that smoking and passive smoking compose the major causes of lung cancer, the arch-enemy of males’ life.

 

A variety of approaches have been developed to realize early diagnosis of lung cancer, among which the In Vitro Diagnostics—crucial component of immunologic diagnosis nowadays receives popularity in the field in that it targets on the lung cancer biomarkers, which can be categorized into 2 subtypes, including small cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC).

 

Creative Biolabs, a conscientious contract research organization (CRO), is providing relative solutions, aiming to assist with the researchers and medicine manufacturers that are working on the diagnosis and treatment of lung cancer.

 

Covered genes:

  • miR-17, miR-3p, miR-21, miR-20b, miR-223, miR-301, Let-7f
  • CYFRA 21-1, EGFR, FAM83B, CR-1, IDH1, ALK gene, PD-L1, NSE, CAXII, CSLEX, TTR, CKAP4

 

Equipped with the high-end platform focused on the IVD antibody development, there are also high-standard antibody design solutions targeting at specific diagnostic markers of lung cancer, which ranges from scratch to commercial IVD test kits, and antibody candidates can be accessed as well.

“Our ultimate goal is to improve precision medicine,” said the head of Creative Biolabs, who has been dedicated in the industry of antibody engineering for over 10 years and has received dozens of successful cases and appraises.

 

In response to the call of the international community, government and groups must take actions to control the use of tobacco, through:

  • Monitoring use and prevention policies
  • Protecting people from smoking and passive smoking
  • Assistance with quitting smoking
  • Warning of tobacco hazards
  • Prohibition of tobacco advertising, promotion and sponsorship
  • Raising tax

 

There are fundamental and irreconcilable conflicts between the interests of tobacco industry and public health policy that products produced and promoted by the tobacco industry are scientifically proven to be addictive, causing disease and death and various social ills, including increasing poverty. Therefore, countries should try their best to prevent the tobacco industry from interfering with the formulation and implementation of public health policies for tobacco control.

Comment Log in or Join Tablo to comment on this chapter...
~

You might like Jerry's other books...